The melanocortin system

Everything else on this site is a detail of this one page — the system the body reuses to keep itself whole.

The melanocortin system is one of biology's most economical signalling arrangements — and that economy is exactly why it has become such fertile ground for medicine. A single gene encodes a single precursor protein — pro-opiomelanocortin, or POMC — which is then cut into a family of short peptides. Those peptides act on five related receptors, are opposed by two natural antagonists, and between them regulate processes as different as the colour of your hair, the cortisol released under stress, how much you eat, and how inflammation resolves.^[1] The economy is the point: the same molecular toolkit is reused across organs, with specificity coming not from the messenger but from where it is made and which receptor receives it. Get this one system, and a surprising slice of human physiology — and a fast-growing shelf of drugs — comes with it.

One gene, many messages

POMC is a prohormone — a long, inert precursor that has to be cut to become active. The cutting is done by enzymes called prohormone convertases, chiefly PC1/3 and PC2, which snip the chain at specific pairs of basic amino acids.^[2] Crucially, different tissues carry different convertases, so the same POMC molecule yields different products depending on where it is processed.^[4]

• In the anterior pituitary, PC1/3 dominates. Processing largely stops at adrenocorticotropic hormone (ACTH) and β-lipotropin.
• In the hypothalamus, intermediate pituitary, and skin, both PC1/3 and PC2 are present, so ACTH is cut further into α-melanocyte-stimulating hormone (α-MSH), and β-lipotropin into β-endorphin.^[2]

This is why ACTH is the dominant pituitary output that drives the adrenal gland, while α-MSH — the classic pigment and appetite signal — is generated in the brain and skin.

The melanocortin peptides

The peptides cut from POMC fall into two functional groups. Themelanocortins proper — α-, β-, and γ-MSH and ACTH — share a common core sequence (His-Phe-Arg-Trp) that is the business end for receptor binding.^[1] Alongside them, the same precursor releases β-endorphin, an opioid peptide, underscoring how much functional range is packed into one gene.^[2]

Different melanocortins prefer different receptors. α-MSH is the broadest agonist; ACTH is the only peptide that meaningfully activates the adrenal receptor; and the relative potencies of β- and γ-MSH vary by receptor subtype.^[3]

Five receptors that read the signal

The melanocortins act through five G-protein-coupled receptors, MC1R through MC5R. All five couple to the stimulatory G-protein Gs, raising intracellular cyclic AMP when activated — a shared mechanism that nonetheless produces very different outcomes because each receptor sits in a different tissue.^[3]

• MC1R — melanocytes; the switch between red/yellow and brown/black pigment.
• MC2R — adrenal cortex; the ACTH receptor that drives cortisol.
• MC3R — hypothalamus and periphery; energy partitioning and inflammation.
• MC4R — central nervous system; the master control of appetite and weight.
• MC5R — exocrine glands; secretion, including sebum.

Two of the receptors are unusual. MC2R responds only to ACTH and cannot even reach the cell surface without a dedicated chaperone, the melanocortin receptor accessory protein MRAP — a reminder that the system's specificity is built from accessory machinery as much as from the receptors themselves.^[3] See the receptor overview for a page on each.

The brakes: agouti and AgRP

Most signalling systems are switched on by agonists and simply fade when the agonist leaves. The melanocortin system is rarer: it has endogenousantagonists that actively oppose it. Agouti signalling protein blocks MC1R in the skin — the mechanism behind the banded coat colour of agouti mice — while agouti-related peptide (AgRP) blocks MC3R and MC4R in the brain, and at MC4R behaves as an inverse agonist, pushing activity below baseline.^[1] The push-and-pull of α-MSH against AgRP in the hypothalamus is one of the body's central controllers of appetite.

What the system does

Because the same peptides reach different receptors in different tissues, the melanocortin system shows up across an unusually wide span of physiology:^[1]

• Pigmentation — α-MSH at MC1R drives protective eumelanin and the UV-tanning response.
• The stress axis — ACTH at MC2R is the final step of the hypothalamic–pituitary–adrenal axis, releasing cortisol.
• Energy balance — α-MSH at MC4R suppresses appetite; loss of MC4R signalling is the commonest single-gene cause of severe obesity.
• Inflammation — melanocortins at MC1R and MC3R are broadly anti-inflammatory and pro-resolving.
• Exocrine and other roles — secretion, natriuresis, sexual function, and thermoregulation all carry a melanocortin contribution.

Why it matters in the clinic

Each of these levers is now a therapeutic target. Agonists of MC4R are used for rare genetic obesity, MC1R agonists for a light-sensitivity disorder, and melanocortin agonists for sexual dysfunction — with a broader anti-inflammatory frontier still being explored. The therapeutics section covers approved and investigational agents, each verified against current sources.

Common questions

What is the melanocortin system?+

A compact signalling system built from one gene. Pro-opiomelanocortin (POMC) is cut, tissue by tissue, into a family of short peptides (α-, β- and γ-MSH and ACTH) that act on five G-protein-coupled receptors, MC1R through MC5R, and are opposed by two natural antagonists, agouti and AgRP. Between them they regulate pigmentation, the cortisol stress axis, appetite and body weight, and inflammation.

Why does one POMC gene produce so many different hormones?+

Because POMC is a prohormone cut by enzymes called prohormone convertases (chiefly PC1/3 and PC2), and different tissues carry different convertases. The same POMC molecule therefore yields different products depending on where it is processed: mostly ACTH in the anterior pituitary, but α-MSH and β-endorphin in the hypothalamus, skin and intermediate pituitary.

What are agouti and AgRP, the system’s natural brakes?+

They are endogenous antagonists, which is rare: most signalling systems are only switched on by agonists. Agouti signalling protein (ASIP) blocks MC1R in the skin, shifting pigment toward pale pheomelanin. Agouti-related peptide (AgRP) blocks MC3R and MC4R in the brain and acts as an inverse agonist at MC4R, driving hunger against α-MSH’s satiety signal.

What does the melanocortin system control in the body?+

Four main axes: pigmentation and UV tanning (α-MSH at MC1R), the cortisol stress axis (ACTH at MC2R), appetite and body weight (α-MSH versus AgRP at MC4R), and inflammation (MC1R and MC3R are broadly anti-inflammatory). Secretion, sodium and blood-pressure balance, sexual function and thermoregulation each carry a melanocortin contribution too.

References

1. 1.Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev. 27(7):736–49. 2006. link ↗
2. 2.Harno E, Gali Ramamoorthy T, Coll AP, White A. POMC: The Physiological Power of Hormone Processing. Physiol Rev. 98(4):2381–2430. 2018. link ↗
3. 3.Ramachandrappa S, Gorrigan RJ, Clark AJL, Chan LF. The melanocortin receptors and their accessory proteins. Front Endocrinol (Lausanne). 4:9. 2013. link ↗
4. 4.Cawley NX, Li Z, Loh YP. Biosynthesis, trafficking, and secretion of POMC-derived peptides. Review (PMC4899099). 2016. link ↗